![](/img/cover-not-exists.png)
PDB18 COMPARISON OF RESOURCES UTILIZATION (RU)AND COST IN DRUG NAÏVE TYPE 2 DIABETES (T2D) PATIENTS TREATED WITH ROSIGLITAZONE (RSG)VS. SULFONYLUREA (SU) MONOTHERAPY
MS Duh, A Gosselin, N Beaulieu, LM Arana, B ArondekarVolume:
11
Year:
2008
Language:
english
DOI:
10.1016/s1098-3015(10)70706-3
File:
PDF, 69 KB
english, 2008